Use of different thresholds of prior antimicrobial use in defining exposure: Impact on the association between antimicrobial use and antimicrobial resistance

Journal of Infection

Volumn 55, Issue 5, 2007, Pages 414-418

  Hyle, Emily P ^a   Gasink, Leanne B ^a   Linkin, Darren R ^a,b   Bilker, Warren B ^a   Lautenbach, Ebbing ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antimicrobial; Fluoroquinolones; FQRPA; Methodology; Resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; IMIPENEM; METRONIDAZOLE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; VANCOMYCIN;

ACCURACY; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EXPOSURE; DRUG USE; HUMAN; MULTIVARIATE ANALYSIS; NONHUMAN; PSEUDOMONAS AERUGINOSA; RISK FACTOR; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; FLUOROQUINOLONES; HUMANS; MULTIVARIATE ANALYSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK FACTORS; TIME FACTORS;

EID: 35349027685     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.07.005     Document Type: Article

References (16)

1. Smolinski M.S., Hamburg M.A., and Lederberg J. Microbial threats to health: emergence, detection, and response (2003), Institute of Medicine, Washington, DC p. 32
2. Patterson J.E. Antibiotic utilization: is there an effect on antimicrobial resistance?. Chest 119 Suppl. 2 (2001) 426S-30S
3. Safdar N., and Maki D.G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136 (2002) 834-844
4. Mendelson G., Hait V., Ben-Israel J., Gronich D., Granot E., and Raz R. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 24 (2005) 17-22
5. Lee S., Lee E., Park S., Kim S., Seo Y., and Cho Y. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 25 (2004) 832-837
6. Paterson D.L., Ko W.C., Von Gottberg A., Mohapatra S., Casellas J.M., Goossens H., et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 40 (2004) 26-32
7. Hyle E.P., Bilker W.B., Gasink L.B., and Lautenbach E. Impact of different methods for describing the extent of prior antibiotic exposure on the association between antibiotic use and antibiotic-resistant infection. Infect Control Hosp Epidemiol 28 (2007) 647-654
8. Gasink L.B., Fishman N.O., Weiner M.G., Nachamkin I., Bilker W.B., and Lautenbach E. Fluoroquinolone-resistant Pseudomonas aeruginosa: Assessment of risk factors and clinical impact. Am J Med 199 (2006) e19-e26
9. Barton T.D., Fishman N.O., Weiner M.G., LaRosa L.A., and Lautenbach E. High rate of coadministration of di- or tri-valent cation-containing compounds with oral fluoroquinolones: risk factors and potential implications. Infect Control Hosp Epidemiol 26 (2005) 93-99
10. Deyo R.A., Cherkin D.C., and Ciol M.A. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45 (1992) 613-619
11. Sun J. A non-parametric test for interval censored failure time data with applications to AIDS studies. Statist Med 15 (1996) 1387-1395
12. Mickey R.M., and Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129 (1989) 125-137
13. Harris A.D., Karchmer T.B., Carmeli Y., and Samore M.H. Methodological principles of case-control studies that anlayzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 32 (2001) 1055-1061
14. Kaye K.S., Harris A.D., Samore M., and Carmeli Y. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect Control Hosp Epidemiol 26 (2005) 346-351
15. Royston P., Altman D., and Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Statist Med 25 (2006) 127-141
16. D'Agata E.M. Methodologic issues of case-control studies: a review of established and newly recognized limitations. Infect Control Hosp Epidemiol 26 (2005) 338-341